Struggling with Standing
The Supreme Court's conservatives are not cutting conservative litigants any slack (and that's a good thing).
The Supreme Court's conservatives are not cutting conservative litigants any slack (and that's a good thing).
The standing requirements laid down by the majority might make it extremely difficult or impossible for victims of indirect goverment censorship to get their cases to court.
Even if one thinks the federal government crossed the line in pushing more aggressive social-media-platform content moderation policies, plaintiffs must still satisfy the traditional requirements of Article III standing.
It's a good policy, authorized by the law. But it will likely face lawsuits, nonetheless, potentially leading to a prolonged legal battle.
In his AHM v. FDA concurrence, Justice Thomas suggests the Court needs to rethink associational standing and questions whether it comports with Article III.
Not a single justice was impressed by the unimpressive standing theories offered in Alliance for Hippocratic Medicine v. FDA.
The decision allows the lawsuit to proceed, albeit with fewer plaintiffs.
The district court recognizes that the plaintiffs lack standing, but grants them leave to amend.
A unanimous panel orders dismissal of Juliana v. United States, bringing this zombie litigation to a close.
If doctors cannot sue the FDA for failing to restrict pharmaceuticals or other products, can anyone else? And if not, is this a problem?
This would virtually ensure the case can't be dismissed for lack of standing, thanks to Missouri's precedent-setting Supreme Court victory in Biden v. Nebraska. The Show Me State can once again really show 'em!
Live commentary on the Supreme Court oral argument in FDA v. Alliance for Hippocratic Medicine
The threshold issue in today's oral argument is Article III standing, and that issue should be determinative.
Another federal appellate judge expresses discontent with current standing doctrine.
The Second Circuit divides over whether an association must identify an injured member by name for the purposes of Article III. (Updated)
The ruling allows the CNVH private sponsorship program - covering migrants from Cuba, Nicaragua, Venezuela, and Haiti to continue. But it is likely to be appealed.
The Court also rejects a late-filed amicus briefs from the American Bar Association, but accepts one from former FDA Commissioners.
The court concludes that, because the plaintiff hadn't applied to be hired, he didn't have standing to challenge the policy.
The Court granted two petitions for certiorari seeking review of a controversial lower court decision limiting federal approval of mifepristone.
The Supreme Court's first decision of the term does not decide very much.
The Court saw no reason to consider the Eighth Circuit's conclusion that the states lacked standing.
Time to brush off your federal courts outlines.
Recent Supreme Court cases suggest that both the left and the right are already repositioning themselves.
Procedure, soundbites, popular views, and more combined to create legally unfounded memes.
Recent reporting doesn't materially undermine, and could even strengthen, the case for standing.
The Court had ample reason to find a "credible threat" of enforcement, consistent with existing case law.
Is the legal left beginning to adopt a hawkish attitude toward standing?
A lawsuit to keep Donald Trump off the Florida primary ballot fails.
If so, please submit it to the Constitutional Law Institute's fall conference!
The Court will consdier whether to invalidate the CFPB's funding, narrow standing, and overturn Chevron, among other things.
The Court unanimously ruled the plaintiffs in that case lacked standing. But they might end up getting what they wanted more fully than anyone else involved in the legal battle over student loan forgiveness.
The Supreme Court did not overturn the standing holding of MAssachusetts v. EPA, but it may have left it on life support.
The 8-1 decision is a major win for Biden and executive enforcement discretion. I think the Court got the right result, but for the wrong reasons.
Years after the Ninth Circuit ordered the case dismissed, it is brought back to life with a surprising trial court order.
The Supreme Court ruled that home equity theft qualifies as a taking, and that state law is not the sole source for the definition of property rights. The ruling is imprecise on some points, but still sets an important and valuable precedent.
The Supreme Court has accepted certiorari in Carnahan v. Maloney to consider whether members of Congress can sue to force disclosure of information from the General Services Administration.
A new report purporting to show that Missouri's arguments for standing in Nebraska v. Biden are based on a lie fails to deliver.
The decision may even be unanimous.
The appeals court's unpublished order avoids some of the district court's errors, but still has some significant problems, especially with regard to standing.
On Good Friday, two district courts issued decisions on the FDA's approval of the abortion drug mifepristone.
And this lawsuit faces many of the same administrative law hurdles as does AHM v. FDA.
ADF's Erin Hawley responds to my post on the jurisdictional problems in AHM v. FDA and I reply.
There's been lots of heat, but very little light in coverage and commentary about the lawsuit seeking to revoke FDA approval of mifepristone.